On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened lower -5.57% from the last session, before settling in for the closing price of $6.28. Price fluctuations for CAPR have ranged from $5.68 to $20.75 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 11.01% over the past five years. Company’s average yearly earnings per share was noted -87.92% at the time writing. With a float of $40.15 million, this company’s outstanding shares have now reached $45.71 million.
Capricor Therapeutics Inc (CAPR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Capricor Therapeutics Inc is 12.17%, while institutional ownership is 36.40%.
Capricor Therapeutics Inc (CAPR) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.38 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.34) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -87.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.88% during the next five years compared to 11.01% growth over the previous five years of trading.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
Check out the current performance indicators for Capricor Therapeutics Inc (CAPR). In the past quarter, the stock posted a quick ratio of 4.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.01 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Capricor Therapeutics Inc (NASDAQ: CAPR) saw its 5-day average volume 1.49 million, a negative change from its year-to-date volume of 1.83 million. As of the previous 9 days, the stock’s Stochastic %D was 16.28%.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 3.60%, which indicates a significant increase from 2.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.36 in the past 14 days, which was lower than the 0.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.57, while its 200-day Moving Average is $9.75. Nevertheless, the first resistance level for the watch stands at $6.21 in the near term. At $6.49, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.64. If the price goes on to break the first support level at $5.78, it is likely to go to the next support level at $5.62. The third support level lies at $5.34 if the price breaches the second support level.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are currently 45,717K shares outstanding in the company with a market cap of 271.10 million. Presently, the company’s annual sales total 22,270 K according to its annual income of -40,470 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,390 K.
